Cargando…
Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma
Biological treatments have been studied extensively and previous studies have proved that osteoprotegerin (OPG) can inhibit the development and progress of human osteosarcoma. However, the utility of biologic agents for cancer therapy has a short half-life, which can hardly deliver to and function i...
Autores principales: | Qiao, Bo, Shui, Wei, Cai, Li, Guo, Shuquan, Jiang, Dianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338779/ https://www.ncbi.nlm.nih.gov/pubmed/25733814 http://dx.doi.org/10.2147/DDDT.S77116 |
Ejemplares similares
-
Therapeutic implications of osteoprotegerin
por: Fili, Sofia, et al.
Publicado: (2009) -
Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition
por: Peng, Lihua, et al.
Publicado: (2018) -
Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells
por: Lee, Hye Ja, et al.
Publicado: (2013) -
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin
por: Corallini, F., et al.
Publicado: (2009) -
Role of osteoprotegerin in the regulation of dental epithelial-mesenchymal signaling during tooth development
por: Gao, Xin, et al.
Publicado: (2019)